Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Another Stab At FDA West Nile Virus Screening Guidance

This article was originally published in The Gray Sheet

Executive Summary

FDA is issuing a new draft guidance Dec. 15 recommending the use of an FDA-licensed nucleic acid test on living donors of cells, tissue and tissue-based products for evidence of infection with West Nile Virus. It updates from a 2013 draft guidance on the same topic that was never finalized.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register